RNA Editing Restores Alpha One Antitrypsin in Mouse Models
Korro disclosed striking mouse pharmacology for a redosable GalNAc RNA editor in alpha-1 antitrypsin deficiency. The dual functional-protein restoration and mutant-protein reduction thesis is biologically attractive, but prior translation failure and absent human data…
